Some Weight Watchers participants are crying foul over a decision by the die-hard diet organization — which once famously helped Oprah Winfrey shed 40 pounds — to offer Ozempic and other ...

Weight Watchers announced the purchase of Sequence, a telehealth platform that can be used to prescribe weight-loss drugs like Ozempic. ... Ozempic and Wegovy are the brand names for semaglutide, ...

"An Oprah Special: Shame, Blame and the Weight Loss Revolution" will air March 18 on ABC with Oprah Winfrey discussing prescription weight-loss injectables like Ozempic, Mounjaro and Wegovy.

That kind of screening around semaglutides is important. Wegovy, which was approved by the FDA in 2021, is designed for weight loss, whereas Ozempic is designed for diabetes management.

But, as my doctor explained, this was about the impact of carrying extra body weight on my joints. Given my lifelong struggles with dieting, he suggested there might be an underlying issue ...

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...

Against all odds, the company formerly known as Weight Watchers still has a place in the world. Founded in 1963, the $550 million weight-loss firm might seem obsolete in the age of fat-shedding ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to Ozempic—called compounded semaglutide. With a price of $129 per month, this ...

Translation, according to the WSJ Pro Bankruptcy section of The Wall Street Journal: the company "has filed for bankruptcy to adjust to the increasing use of drugs like Ozempic for weight loss." ...

Semaglutide was approved by the US Food and Drug Administration to treat type 2 diabetes as Ozempic, but it was also used off-label for weight loss. Wegovy, the version that treats weight loss ...

WeightWatchers' CEO of roughly two years, Sima Sistani, is out. She helped push the company into the white-hot weight-loss drug space. Its interim chief said the company was in a critical period ...